Product Code: GVR-1-68038-400-0
Sterilization Equipment Market Growth & Trends:
The global sterilization equipment market size is expected to reach USD 15.6 billion by 2030, registering a CAGR of 10.75% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising incidence of Hospital Acquired Infections (HAIs), impact of the COVID-19 outbreak, and the increasing number of surgical procedures are the key driving factors of the market. The recent outbreak of COVID-19 is anticipated to significantly impact the market. The pandemic caused by the virus SARS-CoV-2 has drastically increased the demand for medicines, emergency supplies, and hospital equipment including gowns, antiseptics, and disinfectant products.
The COVID-19 outbreak and increasing hospital admissions across the globe have significantly increased the demand for sterilization equipment. Consequently, the use of sterilization equipment has also increased due to the increasing number of patients in hospitals & clinics. Proper and regular sterilization of medical devices is one of the essential requirements for treating patients suffering from COVID-19. In such cases, demand for sterilization equipment is anticipated to increase, which is in turn expected to propel the market growth. Therefore, the outbreak of COVID-19 is a high-impact rendering driver for this market.
Sterilization Equipment Market Report Highlights:
- The low-temperature sterilizers segment held the largest market share of around 32.43% in 2024. Low-temperature sterilization methods, such as vaporized hydrogen peroxide (VHP), ethylene oxide (EtO), and peracetic acid, are ideal for sterilizing heat-sensitive medical devices and materials, including plastics and delicate instruments.
- The low-temperature sterilizers segment is expected to grow at the highest CAGR of 10.98% during the forecast period due to increasing demand for heat-sensitive devices and rising awareness of infection control.
- North America sterilization equipment market dominated with a share of 35.43% in 2024. The increasing prevalence of chronic diseases, such as cancer, heart disease, and diabetes, has significantly increased the hospital admission rate in North America.
Table of Content
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Source
- 1.2.3. Type
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
Chapter 3. Sterilization Equipment Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising prevalence of HAIs
- 3.2.1.2. Growing product launches
- 3.2.1.3. Increasing regulatory approvals
- 3.2.1.4. Increasing awareness of HAIs
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of the devices
- 3.2.3. Market Opportunity Analysis
- 3.2.3.1. Growing acquisitions and mergers among the industry key players
- 3.2.3.2. Increasing focus on environmental sustainability
- 3.3. Sterilization Equipment Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
Chapter 4. Sterilization Equipment Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)
- 4.1. Sterilization Equipment Market: Product Outlook and Key Takeaways
- 4.2. Sterilization Equipment Market: Product Movement Analysis
- 4.3. Sterilization Equipment Market Estimates & Forecast, by Product (USD Million)
- 4.4. Heat Sterilizers
- 4.4.1. Heat Sterilizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2. Depyrogenation Oven
- 4.4.2.1. Depyrogenation Oven Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3. Steam Autoclaves
- 4.4.3.1. Steam Autoclaves Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Low-temperature Sterilizers
- 4.5.1. Low-temperature Sterilizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.2. Ethylene Oxide Sterilizers
- 4.5.2.1. Ethylene Oxide Sterilizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.3. Hydrogen Peroxide Sterilizers
- 4.5.3.1. Hydrogen Peroxide Sterilizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.4. Others
- 4.5.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Sterile Membrane Filters
- 4.6.1. Sterile Membrane Filters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7. Radiation Sterilization Devices
- 4.7.1. Radiation Sterilization Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7.2. Electron Beams
- 4.7.2.1. Electron Beams Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7.3. Gamma Rays
- 4.7.3.1. Gamma Rays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7.4. Others
- 4.7.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Sterilization Equipment Market: Regional Estimates & Trend Analysis
- 5.1. Regional Dashboard
- 5.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
- 5.3. North America
- 5.3.1. U.S.
- 5.3.1.1. Key country dynamics
- 5.3.1.2. Regulatory framework/ reimbursement structure
- 5.3.1.3. Competitive scenario
- 5.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
- 5.3.2. Canada
- 5.3.2.1. Key country dynamics
- 5.3.2.2. Regulatory framework/ reimbursement structure
- 5.3.2.3. Competitive scenario
- 5.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
- 5.3.3. Mexico
- 5.3.3.1. Key country dynamics
- 5.3.3.2. Regulatory framework/ reimbursement structure
- 5.3.3.3. Competitive scenario
- 5.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
- 5.4. Europe
- 5.4.1. UK
- 5.4.1.1. Key country dynamics
- 5.4.1.2. Regulatory framework/ reimbursement structure
- 5.4.1.3. Competitive scenario
- 5.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
- 5.4.2. Germany
- 5.4.2.1. Key country dynamics
- 5.4.2.2. Regulatory framework/ reimbursement structure
- 5.4.2.3. Competitive scenario
- 5.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
- 5.4.3. France
- 5.4.3.1. Key country dynamics
- 5.4.3.2. Regulatory framework/ reimbursement structure
- 5.4.3.3. Competitive scenario
- 5.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
- 5.4.4. Italy
- 5.4.4.1. Key country dynamics
- 5.4.4.2. Regulatory framework/ reimbursement structure
- 5.4.4.3. Competitive scenario
- 5.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
- 5.4.5. Spain
- 5.4.5.1. Key country dynamics
- 5.4.5.2. Regulatory framework/ reimbursement structure
- 5.4.5.3. Competitive scenario
- 5.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
- 5.4.6. Norway
- 5.4.6.1. Key country dynamics
- 5.4.6.2. Regulatory framework/ reimbursement structure
- 5.4.6.3. Competitive scenario
- 5.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
- 5.4.7. Sweden
- 5.4.7.1. Key country dynamics
- 5.4.7.2. Regulatory framework/ reimbursement structure
- 5.4.7.3. Competitive scenario
- 5.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
- 5.4.8. Denmark
- 5.4.8.1. Key country dynamics
- 5.4.8.2. Regulatory framework/ reimbursement structure
- 5.4.8.3. Competitive scenario
- 5.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
- 5.5. Asia Pacific
- 5.5.1. Japan
- 5.5.1.1. Key country dynamics
- 5.5.1.2. Regulatory framework/ reimbursement structure
- 5.5.1.3. Competitive scenario
- 5.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
- 5.5.2. China
- 5.5.2.1. Key country dynamics
- 5.5.2.2. Regulatory framework/ reimbursement structure
- 5.5.2.3. Competitive scenario
- 5.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
- 5.5.3. India
- 5.5.3.1. Key country dynamics
- 5.5.3.2. Regulatory framework/ reimbursement structure
- 5.5.3.3. Competitive scenario
- 5.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
- 5.5.4. Australia
- 5.5.4.1. Key country dynamics
- 5.5.4.2. Regulatory framework/ reimbursement structure
- 5.5.4.3. Competitive scenario
- 5.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
- 5.5.5. South Korea
- 5.5.5.1. Key country dynamics
- 5.5.5.2. Regulatory framework/ reimbursement structure
- 5.5.5.3. Competitive scenario
- 5.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
- 5.5.6. Thailand
- 5.5.6.1. Key country dynamics
- 5.5.6.2. Regulatory framework/ reimbursement structure
- 5.5.6.3. Competitive scenario
- 5.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
- 5.6. Latin America
- 5.6.1. Brazil
- 5.6.1.1. Key country dynamics
- 5.6.1.2. Regulatory framework/ reimbursement structure
- 5.6.1.3. Competitive scenario
- 5.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
- 5.6.2. Argentina
- 5.6.2.1. Key country dynamics
- 5.6.2.2. Regulatory framework/ reimbursement structure
- 5.6.2.3. Competitive scenario
- 5.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
- 5.7. MEA
- 5.7.1. South Africa
- 5.7.1.1. Key country dynamics
- 5.7.1.2. Regulatory framework/ reimbursement structure
- 5.7.1.3. Competitive scenario
- 5.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
- 5.7.2. Saudi Arabia
- 5.7.2.1. Key country dynamics
- 5.7.2.2. Regulatory framework/ reimbursement structure
- 5.7.2.3. Competitive scenario
- 5.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
- 5.7.3. UAE
- 5.7.3.1. Key country dynamics
- 5.7.3.2. Regulatory framework/ reimbursement structure
- 5.7.3.3. Competitive scenario
- 5.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
- 5.7.4. Kuwait
- 5.7.4.1. Key country dynamics
- 5.7.4.2. Regulatory framework/ reimbursement structure
- 5.7.4.3. Competitive scenario
- 5.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
- 6.1. Market Participant Categorization
- 6.2. Recent Developments & Impact Analysis by Key Market Participants
- 6.3. Company Market Share Analysis, 2024
- 6.4. Key Company Profiles
- 6.4.1. ASP (Fortive Corporation)
- 6.4.1.1. Company overview
- 6.4.1.2. Financial performance
- 6.4.1.3. Product benchmarking
- 6.4.1.4. Strategic initiatives
- 6.4.2. Getinge
- 6.4.2.1. Company overview
- 6.4.2.2. Financial performance
- 6.4.2.3. Product benchmarking
- 6.4.2.4. Strategic initiatives
- 6.4.3. STERIS
- 6.4.3.1. Company overview
- 6.4.3.2. Financial performance
- 6.4.3.3. Product benchmarking
- 6.4.3.4. Strategic initiatives
- 6.4.4. Steelco S.p.A.
- 6.4.4.1. Company overview
- 6.4.4.2. Financial performance
- 6.4.4.3. Product benchmarking
- 6.4.4.4. Strategic initiatives
- 6.4.5. Shinva Medical Instrument Co., Ltd.
- 6.4.5.1. Company overview
- 6.4.5.2. Financial performance
- 6.4.5.3. Product benchmarking
- 6.4.5.4. Strategic initiatives
- 6.4.6. MATACHANA
- 6.4.6.1. Company overview
- 6.4.6.2. Financial performance
- 6.4.6.3. Product benchmarking
- 6.4.6.4. Strategic initiatives
- 6.4.7. 3M
- 6.4.7.1. Company overview
- 6.4.7.2. Financial performance
- 6.4.7.3. Product benchmarking
- 6.4.7.4. Strategic initiatives
- 6.4.8. MMM Group
- 6.4.8.1. Company overview
- 6.4.8.2. Financial performance
- 6.4.8.3. Product benchmarking
- 6.4.8.4. Strategic initiatives
- 6.4.9. Stryker
- 6.4.9.1. Company overview
- 6.4.9.2. Financial performance
- 6.4.9.3. Product benchmarking
- 6.4.9.4. Strategic initiatives
- 6.4.10. Andersen Sterilizers
- 6.4.10.1. Company overview
- 6.4.10.2. Financial performance
- 6.4.10.3. Product benchmarking
- 6.4.10.4. Strategic initiatives
- 6.4.11. HUMAN MEDITEK CO., LTD.
- 6.4.11.1. Company overview
- 6.4.11.2. Financial performance
- 6.4.11.3. Product benchmarking
- 6.4.11.4. Strategic initiatives
- 6.4.12. SOLSTEO
- 6.4.12.1. Company overview
- 6.4.12.2. Financial performance
- 6.4.12.3. Product benchmarking
- 6.4.12.4. Strategic initiatives
- 6.4.13. Scitek Global Co., Ltd.
- 6.4.13.1. Company overview
- 6.4.13.2. Financial performance
- 6.4.13.3. Product benchmarking
- 6.4.13.4. Strategic initiatives
- 6.4.14. Renosem
- 6.4.14.1. Company overview
- 6.4.14.2. Financial performance
- 6.4.14.3. Product benchmarking
- 6.4.14.4. Strategic initiatives
- 6.4.15. Labtron Equipment Ltd
- 6.4.15.1. Company overview
- 6.4.15.2. Financial performance
- 6.4.15.3. Product benchmarking
- 6.4.15.4. Strategic initiatives
- 6.4.16. Labotronics Scientific
- 6.4.16.1. Company overview
- 6.4.16.2. Financial performance
- 6.4.16.3. Product benchmarking
- 6.4.16.4. Strategic initiatives
- 6.4.17. Genist Technocracy Pvt. Ltd.
- 6.4.17.1. Company overview
- 6.4.17.2. Financial performance
- 6.4.17.3. Product benchmarking
- 6.4.17.4. Strategic initiatives
- 6.4.18. DE LAMA S.P.A.
- 6.4.18.1. Company overview
- 6.4.18.2. Financial performance
- 6.4.18.3. Product benchmarking
- 6.4.18.4. Strategic initiatives
- 6.4.19. Bionics Scientific (a Unit of Kartal Projects Pvt Ltd.)
- 6.4.19.1. Company overview
- 6.4.19.2. Financial performance
- 6.4.19.3. Product benchmarking
- 6.4.19.4. Strategic initiatives
- 6.4.20. TDK Corporation
- 6.4.20.1. Company overview
- 6.4.20.2. Financial performance
- 6.4.20.3. Product benchmarking
- 6.4.20.4. Strategic initiatives
- 6.4.21. Tuttnauer
- 6.4.21.1. Company overview
- 6.4.21.2. Financial performance
- 6.4.21.3. Product benchmarking
- 6.4.21.4. Strategic initiatives
- 6.4.22. Biobase Biodusty(Shandong), Co., Ltd.
- 6.4.22.1. Company overview
- 6.4.22.2. Financial performance
- 6.4.22.3. Product benchmarking
- 6.4.22.4. Strategic initiatives